Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigation and Modulation of the Mu-Opioid Mechanisms in Migraine (in Vivo)

NCT02964741 is registered in ClinicalTrials.gov with University of Michigan as lead sponsor.

NCT NCT02964741
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02964741 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigation and Modulation of the Mu-Opioid Mechanisms in Migraine (in Vivo)
Lead sponsor
University of Michigan
Phase
Not applicable
Overall status
Terminated
Start date
February 22, 2017
Completion date
August 1, 2021
Enrollment
44 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

migraine